Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Giao hng nhanh, c kim hng trc v i tr d dng
Read ourfull legal disclaimer for more information
Contents: Semaglutide (Peptide Compound)
CU Anschutz Clinical Trial Shows Fewer Heavy Drinking Days PR Newswire AURORA, Colo., July 29, 2026 A study from the University of Colorado Anschutz found that the popular diabetes and weight loss drug reduced heavy drinking and alcohol-related harm in adults with Alcohol Use Disorder AURORA, Colo., July 29, 2026 /PRNewswire/ -- A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy drinking in adults with Alcohol Use Disorder (AUD)
US$ 26.75
US$ 27.83
US$ 29.09
US$ 22.64
US$ 26.54
US$ 25.64
US$ 29.43
